Insider Trading: Alkermes Plc (ALKS.O)
ALKS.O on Nasdaq
31.69USD
17 May 2013
31.69USD
17 May 2013
Price Change (% chg)
$1.36 (+4.48%)
$1.36 (+4.48%)
Prev Close
$30.33
$30.33
Open
$30.31
$30.31
Day's High
$31.78
$31.78
Day's Low
$29.86
$29.86
Volume
1,388,390
1,388,390
Avg. Vol
1,307,106
1,307,106
52-wk High
$32.33
$32.33
52-wk Low
$14.82
$14.82
| MITCHELL PAUL J | Options Exercised: 0 | ||
| Trade Date: | Sunday, 6 Jan 2013 | Price: | 9.91 |
| Title: | Director | Shares Held: | 8,000 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 0 |
Institutional Holders
| % Shares Owned: | 96.06% |
| # of Holders: | 234 |
| Total Shares Held: | 127,924,368 |
| 3 Mo. Net Change: | 6,749,546 |
| # New Positions: | 36 |
| # Closed Positions: | 24 |
| # Increased Positions: | 117 |
| # Reduced Positions: | 87 |
| # Net Buyers: | 30 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Richard Pops |
50 | 2011 | Chairman of the Board, Chief Executive Officer |
Shane Cooke |
50 | 2011 | President |
James Frates |
45 | 2011 | Chief Financial Officer, Senior Vice President |
Gordon Pugh |
54 | 2011 | Chief Operating Officer, Senior Vice President, Chief Risk Officer |
Kathryn Biberstein |
53 | 2011 | Senior Vice President, Chief Compliance Officer, General Counsel, Secretary |
James Botkin |
63 | 2011 | Senior Vice President - Operations |
Elliot Ehrich |
53 | 2011 | Senior Vice President - Research and Development, Chief Medical Officer |
Michael Landine |
58 | 2011 | Senior Vice President - Corporate Development |
Mark Stejbach |
49 | 2012 | Senior Vice President, Chief Commercial Officer |
Mark Skaletsky |
64 | 2011 | Lead Independent Director |
David Anstice |
64 | 2011 | Independent Director |
Floyd Bloom |
75 | 2011 | Independent Director |
Robert Breyer |
68 | 2011 | Independent Director |
Wendy Dixon |
56 | 2011 | Independent Director |
Geraldine Henwood |
2011 | Independent Director | |
Paul Mitchell |
59 | 2011 | Independent Director |

